About Montefiore Headache Center
Clinical Trials at Montefiore Headache Center
During the past decade, Montefiore Headache Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on
average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Montefiore Headache Center" #1 sponsor was "Pfizer" with 6 trials, followed by "ElectroCore INC" with 3 trials
sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Albert Einstein College of Medicine" with 1 trials sponsored and "Allergan"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Montefiore Headache Center"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator and "Migraine Research Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Montefiore Headache Center
According to Clinical.Site data, the most researched conditions in "Montefiore Headache Center" are
"Migraine" (9 trials), "Migraine Disorders" (2 trials), "Acute Migraine" (1 trials), "Chronic Migraine" (1 trials) and "Migraine With Aura" (1 trials). Many other conditions were trialed in "Montefiore Headache Center" in a lesser frequency.
Clinical Trials Intervention Types at Montefiore Headache Center
Most popular intervention types in "Montefiore Headache Center" are "Drug" (10 trials), "Device" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Rimegepant" (3 trials), "Zavegepant" (2 trials), "Active Transcranial Magnetic Stimulation (TMS) Device" (1 trials) and "BHV-3500 (zavegepant)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Montefiore Headache Center
The vast majority of trials in "Montefiore Headache Center" are
15 trials for "All" genders.
Clinical Trials Status at Montefiore Headache Center
Currently, there are NaN active trials in "Montefiore Headache Center".
undefined are not yet recruiting,
5 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Montefiore Headache Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Montefiore Headache Center, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 3 trials that are defined as “Not Applicable".